Evolution of endocrine therapy for advanced prostate cancer: Breakthroughs and resistance mechanisms from traditional antiandrogens to novel AR pathway inhibitors

Ziqiang Liu, Jianhua Xiao, Ziqiang Dong
Letters in Drug Design & Discovery · Elsevier · 2026-10-01 · DOI: 10.1016/j.lddd.2026.100637

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles